INDIANAPOLIS, Oct. 10, 2011 /PRNewswire/ -- Chronic pain affects an estimated 116 million adults in the U.S.—more than the number affected by heart disease, diabetes, and cancer combined, according to a recent report by the Institute of Medicine. At the same time, prescriptions for opioids have increased over the last ten years by 48%, contributing to the nation's growing battle with prescription drug abuse, according to a report by the U.S. Food and Drug Administration.
As a result, healthcare practitioners treating patients with chronic pain are in need of services to help manage the care of their patients while making sure that patients are compliant with their prescribed medications.
AIT Laboratories is launching AIT Pathways, a new suite of services for prescription compliance monitoring that provides data and information to healthcare practitioners who are trying to find a balance between safety, efficacy, and risk in order to meet their patients' needs.
"It isn't enough anymore to just do a urine or a blood test on a patient being prescribed opioids for the management of chronic pain. It is increasingly important to assist the healthcare practitioner in understanding his/her entire patient population and how to better manage the compliance of their patients while they continue to treat patients with legitimate chronic pain," said AIT Manager of Scientific Education Josh Gunn, Ph.D.
AIT is now offering healthcare practitioners the following:
- A urine baseline study offers a comprehensive look at a healthcare practitioner's practice with the ability to benchmark the office's compliance on a state and national level. Based on nearly 200,000 urine samples tested by AIT in 2010, the company is able to show a state-by-state comparison of non-compliance. To view the percentages of non-compliance by state, visit